How can we predict behavior of nanoparticles in vivo?

Nanomedicine

Volumn 11, Issue 3, 2016, Pages 189-192

  Polyak, Boris ^a   Cordovez, Bernardo ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Optofluidics Inc   (United States)

Author keywords

nanomedicine; nanoparticle biological identity; nanoparticles; protein corona; structure activity models

Indexed keywords

NANOPARTICLE; PROTEIN CORONA;

ANALYTIC METHOD; DRUG DELIVERY SYSTEM; IN VIVO STUDY; NANOMEDICINE; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; STRUCTURE ACTIVITY RELATION; SURFACE PROPERTY; ANIMAL; HUMAN;

ANIMALS; HUMANS; NANOPARTICLES;

EID: 84956941027     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.15.192     Document Type: Review

References (17)

1. Lynch I, Salvati A, Dawson KA. Protein-nanoparticle interactions: what does the cell see? Nat. Nanotechnol. 4(9), 546-547 (2009).
2. Rahman M, Laurent S, Tawil N, Yahia L, Mahmoudi M. Protein-nanoparticle interactions. In: Biophysics 15. Springer-Verlag, Berlin, Heidelberg, Germany (2013).
3. Monopoli MP, Walczyk D, Campbell A et al. Physicalchemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 133(8), 2525-2534 (2011).
4. Brun E, Sicard-Roselli C. Could nanoparticle corona characterization help for biological consequence prediction? Cancer Nanotechnol. 5(1), 7 (2014).
5. Del Pino P, Pelaz B, Zhang Q, Maffre P, Nienhaus GU, Parak WJ. Protein corona formation around nanoparticles-from the past to the future. Materials Horizons 1(3), 301-313 (2014).
6. Cedervall T, Lynch I, Lindman S et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl Acad. Sci. USA 104(7), 2050-2055 (2007).
7. Tenzer S, Docter D, Rosfa S et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: A comprehensive quantitative proteomic analysis. ACS Nano 5(9), 7155-7167 (2011).
8. Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V. Time evolution of the nanoparticle protein corona. ACS Nano 4(7), 3623-3632 (2010).
9. Monopoli MP, Pitek AS, Lynch I, Dawson KA. Formation and characterization of the nanoparticle-protein corona. Methods Mol. Biol. 1025 137-155 (2013).
10. Jiang X, Weise S, Hafner M et al. Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding. J. R. Soc, Interface 7(Suppl. 1), S5-S13 (2010).
11. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl Acad. Sci. USA 105(38), 14265-14270 (2008).
12. Tassa C, Duffner JL, Lewis TA et al. Binding affinity and kinetic analysis of targeted small molecule-modified nanoparticles. Bioconjug. Chem. 21(1), 14-19 (2010).
13. Walkey CD, Olsen JB, Guo H, Emili A, Chan WC. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 134(4), 2139-2147 (2012).
14. Walkey CD, Olsen JB, Song F et al. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 8(3), 2439-2455 (2014).
15. Schein P, Kang P, O'dell D, Erickson D. Nanophotonic force microscopy: characterizing particle-surface interactions using near-field photonics. Nano Lett. 15(2), 1414-1420 (2015).
16. Liu R, Jiang W, Walkey CD, Chan WC, Cohen Y. Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties. Nanoscale 7(21), 9664-9675 (2015).
17. Gentleman DJ, Chan WC. A systematic nomenclature for codifying engineered nanostructures. Small 5(4), 426-431 (2009).